ReviewRheumatology (Oxford, England)2019

JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis.

George E Fragoulis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.